Skip to main content

Table 4 Meta-regression for 30-day mortality

From: Glycoprotein IIb/IIIa inhibitors for cardiogenic shock complicating acute myocardial infarction: a systematic review, meta-analysis, and meta-regression

  n I2 Qdf (p) Coef (p)
Age 5 61.32% 7.323 (0.062) − 0.307 (0.210)
Gender 6 51.72% 8.724 (0.068) 4.475 (0.169)
Diabetes mellitus 6 68.09% 10.424 (0.034) − 0.849 (0.708)
Hypertension 3 85.10% 6.711 (0.010) 6.832 (0.387)
Tobacco use 4 81.47% 8.1112 (0.017) 6.774 (0.456)
Invasive ventilation 5 77.08% 10.6143 (0.014) − 0.165 (0.893)
TIMI flow 0/1 pre procedure 5 77.28% 10.6813 (0.014) − 0.288 (0.807)
IABP use* 6 0.00% 3.7624 (0.439) − 1.565 (0.005)
LVEF 3 0.00% 0.0021 (0.989) − 0.665 (0.368)
Left main stenosis 4 41.01% 3.2792 (0.194) − 15.572 (0.851)
  1. n number of studies included in the analysis, TIMI thrombolysis in myocardial infarction, IABP intraortic balloon pump, LVEF left ventricular ejection fraction